NEWARK, N.J., Dec. 7, 2010 /PRNewswire/ -- BioNeutral Group, Inc., (OTC Bulletin Board: BONU), a specialty life science technology-based company, today announced it has been invited to introduce its Collagiene™ product line to the Oakland City University housekeeping staff in Oakland City, Indiana. The Collagiene™ line of products has been designed to meet the special needs for cleaning and odor neutralizing all areas in the university including the classrooms, gymnasiums, living quarters, halls, offices and restrooms.
Brian Baker, Director of Advancement for Oakland City University, stated, "BioNeutral has a great product line. I look forward to meeting BioNeutral's sales staff and introducing these products to the Oakland University housekeeping staff."
Dr. Andy Kielbania, Chief Scientist of BioNeutral, added, "We specially designed our new Collagiene™ product line with the features and benefits necessary to address the cleaning and deodorizing needs of universities and colleges. We are especially pleased with this invitation from Oakland City University and look forward to working with additional colleges and universities."
About Oakland City University
In June 1885, the Educational Board of General Baptists gained a charter from the state of Indiana to operate a college at Oakland City. Oakland City College opened its doors for classes in 1891, in a two-story brick structure that housed the administration and classrooms, on 10 acres of land donated by Colonel William A. Cockrum. In addition to its liberal arts and theological school, the college had added a large industrial and agricultural department. The university became fully accredited by the Higher Learning Commission of the North Central Association of Colleges and Schools on April 13, 1977, gained full accreditation by the National Council for the Accreditation of Teacher Education in 1981, and expanded its programming to offer five graduate degrees and more than forty undergraduate programs. In addition, the establishment of the Chapman School of Religious Studies provided a home for the only General Baptist seminary in the nation. The college achieved university status in 1995. See www.oak.edu for more info.
About BioNeutral Group, Inc.
Headquartered at the New Jersey Institute of Technology/EDC in Newark, BioNeutral Group, Inc., is a specialty technology-based life science company which has developed a technology platform that neutralizes harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. BioNeutral's products, Ygiene and Ogiene, kill germs and clean surfaces with a dramatic increase in speed and power over their rivals in the marketplace. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. Its antimicrobial line of products under the Ygiene™ brand have been submitted to the EPA for approval for sale in the United States and has already been approved for sale in Germany and is permitted to be sold in the UK, France and Sweden. AutoNeutral is a Registered trademark of BioNeutral Group, Inc. For more information on BioNeutral, including a listing of company products, leadership and background please visit www.bioneutralgroup.com.
Find us on Facebook: http://www.facebook.com/pages/BioNeutral-Group/149109938452393
Follow us on Twitter: http://twitter.com/bioneutralgroup
This release contains certain "forward-looking statements" relating to the business of the Company and its subsidiary companies. These forward-looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions. Such forward looking statements involve known and unknown risks and uncertainties that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Investors should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those described in the Company's filings with the Securities and Exchange Commission. BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene™ and are not yet available for sale in the United States.
SOURCE BioNeutral Group, Inc.